Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;2(2):181-97.
doi: 10.3390/nu2020181. Epub 2010 Feb 11.

Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR: LA-cp rats

Megan R Ruth  1 , Ye Wang, Howe-Ming Yu, Susan Goruk, Martin J Reaney, Spencer D Proctor, Donna F Vine, Catherine J Field
Affiliations

Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR: LA-cp rats

Megan R Ruth et al. Nutrients. 2010 Feb.

Abstract

This study assessed the long-term effects of dietary vaccenic acid (VA) and elaidic acid (EA) on plasma and splenocyte phospholipid (PL) composition and related changes in inflammation and splenocyte phenotypes and cytokine responses in obese/insulin resistant JCR:LA-cp rats. Relative to lean control (Ctl), obese Ctl rats had higher serum haptoglobin and impaired T-cell-stimulated cytokine responses. VA and EA diets improved T-cell-stimulated cytokine production; but, only VA normalized serum haptoglobin. However, EA- and VA-fed rats had enhanced LPS-stimulated cytokine responses. The changes elicited by VA were likely due changes in essential fatty acid composition in PL; whereas EA-induced changes may due to direct incorporation into membrane PL.

Keywords: cytokines; elaidic acid; immune; inflammation; obese; phospholipid; trans fat; vaccenic acid.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mitogen-stimulated IL-2 production. Bars represent mean ± SEM, n=8/group. Bars not sharing a common letter are significantly different (P < 0.05). Ctl, control; VA, vaccenic acid; EA, elaidic acid.
Figure 2
Figure 2
LPS-stimulated cytokine production. Bars represent mean ± SEM, n=8/group. Bars not sharing a common letter are significantly different (P < 0.05). Ctl, control; VA, vaccenic acid; EA, elaidic acid. TNF-α production did not differ among groups (458 ± 42, n = 32).
See this image and copyright information in PMC

References

    1. Yaqoob P. Lipids and the immune response: from molecular mechanisms to clinical applications. Curr. Opin. Clin. Nutr. Metab. Care. 2003;6:133–150. - PubMed
    1. Willett W.C., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., Rosner B.A., Sampson L.A., Hennekens C.H. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581–585. - PubMed
    1. Ascherio A., Hennekens C.H., Buring J.E., Master C., Stampfer M.J., Willett W.C. Trans-fatty acids intake and risk of myocardial infarction. Circulation. 1994;89:94–101. - PubMed
    1. van de Vijver L.P., Kardinaal A.F., Couet C., Aro A., Kafatos A., Steingrimsdottir L., Amorim Cruz J.A., Moreiras O., Becker W., van Amelsvoort J.M., Vidal-Jessel S., Salminen I., Moschandreas J., Sigfusson N., Martins I., Carbajal A., Ytterfors A., Poppel G. Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur. J. Clin Nutr. 2000;54:126–135. doi: 10.1038/sj.ejcn.1600906. - DOI - PubMed
    1. Micha R., Mozaffarian D. Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot. Essent. Fatty Acids. 2008;79:147–152. - PMC - PubMed

Publication types